Follow Prostate Cancer UK

Tags

men united 31 prostate cancer uk 27 owen sharp 23 prostate cancer 16 football 13 scotland 11 nice 8 movember 7 mark bishop 7 enzalutamide 7 men united v prostate cancer 6 abiraterone 6 football league 5 nhs scotland 5 fundraising 5 cycling 5 scottish medicines consortium 5 the movember foundation 4 health 4 nhs 4 drug appraisal 4 smc 4 michael owen 3 research 3 the football league 3 kenney jones 3 scotmid co-operative 3 luther blissett 3 music 3 n 2 tenovus 2 eastenders 2 craig millar 2 the institute of cancer research 2 london to amsterdam 2 hurtwood park polo club 2 running 2 fiona dunlop 2 damian lewis 2 keyline 2 london marathon 2 bill bailey 2 the faces 2 rugby league cares 2 manvan 2 father's day 2 flaming grill 1 preston north end 1 brighton 1 services 1 the university of manchester 1 saxon classic 1 princess margaret cancer centre 1 celebrity 1 spirit pub company 1 jeff stelling 1 iceland charity amateur golf classic 1 strategy 1 london centre of excellence 1 bristol 1 fulham 1 royal mail 1 jurassic classic 1 roberto martinez 1 one in four tour 1 poker stars 1 simon grayson 1 diagnostic tool 1 harry redknapp 1 northern ireland 1 motherwell fc 1 sir michael parkinson 1 erectile dysfunction 1 men united arms 1 errol 1 british journal of cancer 1 sir david attenborough 1 heriot-watt university 1 deloitte 1 virgin london marathon 1 pentel 1 london 1 virgin money london marathon 1 bmc medicine 1 iceland 1 living with and beyond prostate cancer 1 rock horsepower 1 scotmid 1 viv anderson 1 go dad run 1 baun 1 support groups 1 firstgroup 1 golf 1 ultrasound 1 isle of man 1 advanced prostate cancer 1 nik kershaw 1 access to treatments 1 the wellness clinic 1 millwall football club 1 heather blake 1 genetic testing 1 the royal marsden nhs foundation trust 1 majestic wine 1 university of dundee 1 klaxons 1 grand depart classic 1 rockhorsepower 1 colin jackson 1 zytiga 1 movember uk 1 lads night in 1 album 1 the charity challenge 1 worcester 1 richard dunkley 1 storm model management 1 matt holland 1 health care 1 timothy west 1 stormont 1 diagnosis 1 edinburgh marathon 1 karmarama 1 stan carter 1 scottish government 1 icap 1 cancer research uk 1 support 1 icap charity day 1 magic weekend 1 charity of choice 1 awareness 1 mri 1 university of glasgow 1 rod stewart 1 charity of the year 1 ten years to tame 1 psa testing 1 football to amsterdam 1 maggie's 1 the who 1 grand depart 1 psa screening 1 queen’s university belfast 1 side effects 1 rugby league 1 tour de france 1 james beeby 1 incontinence 1 relationships scotland 1 research funding 1 charles dance 1 will carling 1 michael hoppen gallery 1 cardiff 1 cancer support scotland 1 Russ Green 1 marathon 1 sport 1 watford football club 1 league managers association 1 Show all tags
Media no image

Prostate Cancer UK: NICE and Astellas must work together to reverse disappointing decision for men

Press Releases   •   Jun 11, 2015 09:00 BST

Today (Thursday 11 June 2015) the National Institute of Health and Care Excellence (NICE) has announced its draft decision not to recommend advanced prostate cancer drug – enzalutamide – for use before chemotherapy on the NHS in England.

Media no image

Janssen and NICE must continue negotiations until vital prostate cancer drug is made available – says Prostate Cancer UK

Press Releases   •   Aug 15, 2014 09:00 BST

Today (Friday 15 August 2014) the National Institute for Health and Care Excellence (NICE) confirmed its refusal to let men with advanced prostate cancer have a drug which could extend life and delay their need for chemotherapy with its devastating side effects.

Media no image

Prostate cancer drug enzalutamide still denied to those who have had abiraterone

Press Releases   •   Jul 23, 2014 09:00 BST

Imminent Cancer Drugs Fund decision now last resort

Media no image

Charity implores Janssen and NICE to work through issues as prostate cancer drug faces rejection

Press Releases   •   May 14, 2014 09:00 BST

A drug which could delay the need for men with advanced prostate cancer to have chemotherapy has been rejected by the National Institute of Health and Care Excellence (NICE) in a draft decision published today (Wednesday 14 May 2014).

Media no image

Prostate Cancer UK cautiously welcomes NICE decision on advanced prostate cancer drug

Press Releases   •   May 09, 2014 09:00 BST

Today the National Institute for Health and Care Excellence has released final guidance on the use of advanced prostate cancer drug enzalutamide in England and Wales, stating that it is now approved for use on the NHS for men who have already been treated with the chemotherapy drug docetaxel.

Media no image

NICE urged to see sense and remove cruel enzalutamide restrictions

Press Releases   •   Mar 19, 2014 09:00 GMT

Today, 19th March 2014, the National Institute for Health and Care Excellence (NICE) is holding its final committee meeting to appraise advanced prostate cancer drug enzalutamide for use on the NHS in England and Wales for men who have already had chemotherapy. Since January Prostate Cancer UK has been spearheading a campaign against proposed restrictions in access to the life-extending treatment.

Media no image

New hormone therapy could increase prostate cancer survival, study shows

Press Releases   •   Jan 31, 2014 09:00 GMT

Enzalutamide, a new life extending prostate cancer drug, could prolong survival for men with advanced prostate cancer and delay the need for chemotherapy for as long as 17 months according to new research presented at the American Society of Clinical Oncology’s Genitourinary Cancers Conference.

Media no image

NICE draft decision on Enzalutamide an ‘blatant u-turn’ say Prostate Cancer UK

Press Releases   •   Jan 28, 2014 09:00 GMT

Enzalutamide, a new life extending prostate cancer drug, may be made available on the NHS. This is according to a draft decision by the National Institute for Health and Care Excellence (NICE). The decision, which will now enter consultation, will restrict the use of the drug to those men with advanced cancer who have not already had the drug abiraterone.